Business
Also, Clanwilliam has formally established its ANZ division.
The company will use the funds to accelerate its AI capabilities and for strategic and commercial growth.
Business model is unsustainable due to a challenging reimbursement environment and escalating operating costs, company says.
The health tech giant reported lower-than-expected sales and profits in the first quarter, resulting in its shares plummeting.
GenAI company for health plans Alaffia Health and oncology-focused clinical-trial platform Klineo also secured funding.
The wearable-tech company broadened its reach to 56 markets worldwide, added Italian and Latin American Spanish to its app and appointed three C-suite executives.
It is envisioned to cover greater distances, serving Australia's rural and remote communities, while being sustainable.
The telemedicine giant reported a net loss of $81.9 million in the first quarter of the year and a 20% increase in EBITDA year-over-year.
The startup plans to use the funds to build out its technology platform.
The ODU-led team will assess the commercial viability and feasibility of digital environments for people who are visually impaired.